Skip to main content
. 2019 Dec 21;54(6):447–454. doi: 10.1093/abm/kaz062

Table 3.

Abstinence rates at follow-ups by treatment condition (N = 53)

Treatment condition 7-day Point-prevalence Abstinence Self-report                    Cotinine test 3-M prolonged abstinence Self-report and Cotinine test
1-Ma F/Ub 2-M F/U 3-M F/U 3-M F/U 3-M F/U
Treatment arm 63.0% 74.1% 40.7% 37.0% 37.0%
Control arm 61.5% 57.7% 26.9% 23.1% 15.4%

Note: a= month, b = follow-up.